You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Total neoadjuvant chemotherapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer by MRI-guided Radiotherapy

Not yet recruiting
  • Rectal Cancer
  • Radiotherapy with MRIdian with simultaneous integrated boost
  • Questionnaires before, during and after radiotherapy
  • (no location specified)
Jun 13, 2023

Colon Cancer Trial (Neoadjuvant chemo)

Not yet recruiting
  • Colon Cancer
  • Neoadjuvant chemotherapy
  • (no location specified)
Oct 25, 2023

Rectal Cancer Trial in Hangzhou (Envafolimab)

Recruiting
  • Rectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
May 4, 2023

Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)

Not yet recruiting
  • Colon Neoplasm
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Jun 25, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Oct 26, 2023

Esophageal Cancer Trial in Moscow (Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.,

Recruiting
  • Esophageal Cancer
  • Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
  • Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy
  • Moscow, Russian Federation
    N.N. Blokhin National Medical Research Center of Oncology
Oct 2, 2022

Colon Cancer, Neoadjuvant Therapy Trial in Hangzhou (Camrelizumab , apatinib and chemo)

Recruiting
  • Colon Cancer
  • Neoadjuvant Therapy
  • Camrelizumab , apatinib and chemotherapy
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Jan 27, 2023

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of

Not yet recruiting
  • Organoids
  • +2 more
  • Biopsy
  • (no location specified)
Nov 24, 2023

NSCLC Trial in Guangzhou (Total body PET/CT (uExplorer))

Recruiting
  • Non-small Cell Lung Cancer
  • Total body PET/CT (uExplorer)
  • Guangzhou, Guangdong, China
    Hui Liu
Jan 25, 2021

Breast Cancer Trial in Paris (Activity tracker)

Recruiting
  • Breast Cancer
  • Activity tracker
  • Paris, France
  • +2 more
Dec 13, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in São Paulo (PHESGO)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • São Paulo, Brazil
    Centro Paulista de Oncologia (Oncoclínicas)
Oct 3, 2023

Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

Recruiting
  • Esophagus Cancer
  • Xiamen, Fujian, China
    ShanghaiZhongshan
Apr 8, 2023

Head and Neck Squamous-cell Carcinoma

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
    • (no location specified)
    Nov 5, 2023

    Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

    Recruiting
    • Non-Small Cell Lung Cancer
    • Neoadjuvant immunochemotherapy
    • Neoadjuvant chemotherapy
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Aug 1, 2023

    Gastric Cancer Trial in Shijiazhuang (Robot-assisted D2 distal gastrectomy)

    Recruiting
    • Gastric Cancer
    • Robot-assisted D2 distal gastrectomy
    • Shijiazhuang, Hebei, China
      Fourth Affiliated Hospital of Hebei Medical University
    Feb 5, 2023

    Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

    Recruiting
    • Locally Advanced Colorectal Carcinoma
    • Beijing, Beijing, China
      Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
    Nov 23, 2023

    Rectal Tumors Trial in Larissa (Neoadjuvant Chemoradiotherapy, Adjuvant Chemotherapy, Consolidation Chemotherapy)

    Not yet recruiting
    • Rectal Neoplasms
    • Neoadjuvant Chemoradiotherapy
    • +2 more
    • Larissa, Greece
      Department of Surgery, University Hospital of Larissa
    Aug 10, 2022

    Breast Cancer Trial in Naestved (Prehabilitation program)

    Recruiting
    • Breast Cancer
    • Prehabilitation program
    • Naestved, Denmark
      Department of Clinical Oncology and Palliative Care, Zealand Uni
    Jan 31, 2023

    Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva Trial (Paclitaxel and Carboplatin, Chemoradiation)

    Not yet recruiting
    • Locally Advanced Vulvar Carcinoma
    • Squamous Cell Carcinoma of the Vulva
    • Paclitaxel and Carboplatin
    • Chemoradiation
    • (no location specified)
    Jun 6, 2023

    Micrometastases in Axillary Lymph Nodes in Breast Cancer,

    Completed
    • Micrometastases
    • Neoadjuvant Chemotherapy
    • Sentinel lymph node biopsy, axillary lymph node dissection
    • (no location specified)
    Nov 20, 2023

    New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

    Enrolling by invitation
    • Ovarian Cancer
    • +2 more
    • CRS scoring
    • Routine blood laboratory testing before treatment
    • Guangzhou, Guangdong, China
      The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Nov 2, 2023

    Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)

    Not yet recruiting
    • Osteosarcoma
    • (no location specified)
    Jun 29, 2023

    Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)

    Recruiting
    • Breast Cancer
    • Radiotherapy
    • SBRT anticipated boost
    • Bologna, Italy
      IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Jan 9, 2023

    Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

    Recruiting
    • Triple Negative Breast Cancer
    • +3 more
    • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 15, 2023

    Locally Advanced Rectal Carcinoma Trial (Cadonilimab Injection, Short-course radiotherapy, Consolidation chemo)

    Not yet recruiting
    • Locally Advanced Rectal Carcinoma
    • Cadonilimab Injection
    • +2 more
    • (no location specified)
    Mar 19, 2023